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Background: Despite strict avoidance, severely food-allergic children experience frequent and potentially severe
food-induced anaphylaxis (FSFA). There are no accepted preventive interventions for FSFA. A Traditional Chinese
Medicine (TCM) formula prevents anaphylaxis in murine food allergy models, and has immunomodulatory effects in
humans. We analyzed the effects of TCM treatment on three pediatric patients with FSFA.
Case description: Three FSFA patients (P) ages 9–16 years (P1 allergic to milk; P2 and P3 to tree nuts) qualified for
case analysis. All experienced numerous reactions requiring administration of rescue medications and emergency
room (ER) visits during the 2 years prior to starting TCM. P1 experienced approximately 100 reactions, 50 epinephrine
administrations, 40 ER visits, and 3 admissions to intensive care units. P2 experienced 30 reactions, all requiring
epinephrine administration, as well as 10 emergency hospitalizations. P3 experienced 400 reactions, five of which
required epinephrine administration and ER visits. TCM treatment markedly reduced or eliminated reactions in all.
P1 experienced no reactions after 2.5 years of TCM. P2 experienced no reactions after 1 year of TCM treatment, at
which time she passed an oral almond food challenge. She continues to be reaction-free 6 months off TCM while
consuming nuts. P3 has achieved a 94% reduction in reaction frequency following 7 months of TCM, has discontinued
daily antihistamine use, and has required no epinephrine administrations or ER visits.
Conclusions: Three children treated with TCM experienced dramatic reductions or elimination of FSFA. This regimen
appears to present a potential option for FSFA, and warrants further investigation in controlled clinical studies.
Keywords: Traditional Chinese medicine, Food allergy, Food induced anaphylaxisBackground
Food allergy is a leading cause of anaphylactic reactions
treated in emergency departments in the United States
[1,2], where it accounts for 31% of anaphylaxis cases [3],
and is a growing public health concern. Anaphylaxis is
an acute potentially fatal systemic type I hypersensitivity
reaction [4]. The most cited working definition of food
anaphylaxis (FA) was proposed by Sampson and collea-
gues in 2006 [4,5]. FA is acute onset of an illness with
involvement of skin/mucosal tissue, airway compromise,
and gastrointestinal symptoms, or reduced blood pressure
and associated symptoms [1,5]. The most dangerous* Correspondence: xiu-min.li@mssm.edu
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unless otherwise stated.symptoms include breathing difficulties, a drop in blood
pressure, and shock, which are potentially life-threatening.
Given the increased awareness of food allergy by consu-
mers and food manufacturers, frequency of accidental
exposures appears to have been reduced [6,7]. A recent
study reported that the annualized reaction rate in milk,
egg and peanut allergic children was 0.81 per year [6].
However, extremely food-allergic children experience
more frequent and potentially severe food-induced ana-
phylaxis (described herein as FSFA) despite attempted
strict avoidance. Although the majority of food-induced
reactions are triggered by ingestion; in extremely sensitive
children severe reactions can also be triggered by inhal-
ation [8,9] and skin contact [10,11]. Additional interven-
tions that prevent frequent and potentially severe reactions
while practicing food avoidance are urgently needed.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tem that primarily uses Chinese herbal medicines, acu-
puncture and acupressure. TCM has a long history of
human use in China, Japan and Korea, and is beginning
to play a role in the healthcare systems in the United
States and other Western countries as a stand-alone or
integrative practice. Unlike in Asia, the European Union
and the UK [12], Chinese herbal medicines in the U.S
are classified as dietary supplements [13]. In 2004, the
US Food and Drug Administration (FDA) provided guid-
ance for investigating botanical drug products including
formulas comprised of multiple herbal constituents [14].
Although preclinical and clinical studies are limited,
several suggest that TCM herbal formulas may have
potential for treating food allergies [15,16]. Food
Allergy Herbal Formula (FAHF)-1, FAHF-2, and butanol-
extracted FAHF-2 (B-FAHF-2) (derived from the clas-
sical TCM formula Wu Mei Wan) prevent systemic
anaphylaxis in murine models of food allergies [17-19]; and
have been US FDA approved as botanical investigational
new drugs. Phase I clinical studies showed that FAHF-2 is
safe, had an immunomodulatory effect on T cells and sup-
pressed basophil activation [20,21]. Herbal Formula-3
inhibited food allergy reactions in rats by stabilizing mast
cells by modulating calcium mobilization [22]. The trad-
itional Japanese herbal medicine Kakkonto suppressed the
occurrence of allergic diarrhea and decreased the number
of mast cells in the proximal colons in a murine food
allergy model [23]. In addition, acupuncture has been re-
ported to reduce wheal size following allergen skin tests
and to reduce basophil activation in individuals with atopic
dermatitis [24,25]. In addition, we investigated the effects
of extracts of 70 TCM herbs on cultured human B cells,
and found that several directly suppressed IgE synthesis
[26]. Potential TCM effects on FSFA in children have not
been previously investigated. This retrospective study of 3
pediatric patients with extraordinarily severe FSFA shows,




Individuals selected for this report met the following cri-
teria: physician (allergist) diagnosed severe food allergy
(as documented by physician-determined history of al-
lergic reactions to food allergen, a positive skin test
result and/or elevated food allergen specific IgE level),
clinical reactions that became worse over time prior
to TCM treatment, and experienced FSFA including
multiple life-threatening episodes (>10 reactions and >2
epinephrine uses in the 3 months prior to starting TCM
therapy), adherence to the TCM regimen, and had
completed at least 6 months of TCM therapy.Exclusion criteria
FSFA patients concurrently treated with omalizumab
and TCM.
Laboratory tests
Since each patient had a unique clinical situation, this
information was included within the description of each
case.
TCM therapy
TCM therapy consisting of Modified Pruni Mume
Formula (Remedy A), Fructus Jujubae Formula (Remedy
B), a Phellodendron chinensis (P. chinesis) containing
herbal bath additive (Remedy C), and herbal cream
(Remedy D) (Additional file 1: Herbal constituents
and doses). Remedies A and B were used as dietary
supplements. Use of additional herbs is noted in each
case discussion when applicable. Acupuncture/acu-
pressure was also administered during TCM clinic visits.
Patients were seen at the Ming Qi Natural Health
Care Center, Integrative Health and Acupuncture in
New York City.
Visits
All patients had to have at least one initial clinical visit
and completed 6 months of TCM treatment. Since the
treatment courses of individual cases varied, the number
of revisits varied and is described in each case.
Safety and efficacy parameter
Safety and tolerability is defined by no TCM remedy
related reactions, and no abnormal liver and kidney
function test result (aspartate amino transferase (AST),
alanine amino transferase (ALT) and blood urea nitrogen
(BUN) levels when data were available. The efficacy
parameter was based on prevention of frequent reac-
tions, reduced medication use and ER visits (Table 1),
reduction of individual (Figure 1), and total symptom
scores (Figure 2), using a modified version of the Grad-
ing of Food-Induced Anaphylaxis [27] (Additional file 1:
Table S1). Data were obtained from patient history
forms and interviews before, during, and after the TCM
treatment course of February 2011 through February 2014.
Data were collected every 3 months during the first year,
and every 6 months after one year of TCM treatment. In
addition, Quality of Life/Distress over time (using a modi-
fied version of the “Food hypersensitivity family impact




Patient 1 (P1), a 13-year old female with physician-diag-
nosed severe milk allergy began TCM in February 11, 2011
Table 1 Frequency of reaction, medication use and ER visits before, during and after TCM therapy
# of uses or occurrences 2 year period before TCM During and after the courses of TCM
Total Ave./Year Prior 3 M 1-3 M 4-6 M 7-9 M 10 – 12 M 1 - 1.5 Y 1.5- 2 Y 2 - 2.5 Y
Patient 1
Allergic Reactions 100 50 10 8 3 3 2 1 1 0
Epinephrine 50 25 5 3 1 1 1 0 0 0
Diphenhydramine (p.r.n.) 100 50 10 8 3 3 2 1 1 0
Prednisone 50 25 5 5 1 1 1 0 0 0
ER visits 40 20 5 0 0 0 0 0 0 0
Patient 2
Allergic Reactions 30 15 10 1 2 1 0 0 0** ND
Epinephrine 34 17 10 0 0 0 0 0 0** ND
Cetirizine (daily) 730 365 93 30 0 0 0 0 0** ND
Cetirizine (p.r.n.) 30 15 10 1 0 0 0 0 0** ND
Diphenhydramine (daily) 730 365 93 30 0 0 0 0 0** ND
Diphenhydramine (p.r.n.) 30 15 10 1 1 1 0 0 0** ND
Prednisone 2 NA* 1 0 0 0 0 0 0** ND
ER visits 10 5 5 0 0 0 0 0 0** ND
Patient 3
Allergic Reactions 400 200 45 10 2 1 ND ND ND ND
Epinephrine 5 2.5 2 1 0 0 ND ND ND ND
Diphenhydramine (p.r.n.) 400 200 45 10 2 1 ND ND ND ND
Levocetirizine (daily) 730 365 90 60 30 0 ND ND ND ND
Fexofenadine (daily) 730 365 90 60 0 0 ND ND ND ND
Prednisone 5 2.5 0 1 0 0 ND ND ND ND
ER visits 5 2.5 1 1 0 0 ND ND ND ND
Reactions, medication use and ER visits during the prior 2-year period history and during treatment were documented in patient history forms. Patient 1 has
completed 2.5 years of TCM treatment. She experienced no reactions during the last 6 months of her TCM course, but continues TCM treatment because she has
not yet undergone a food allergy challenge. Patient 2 stopped TCM after 1 year, due to absence of reactions and a successful food allergy challenge. Patient 3 has
completed 7 months of TCM, and has experienced a marked reduction in food allergy reactions. He continues TCM therapy. Daily, daily use as preventive treatment. p.r.
n., use as needed. *NA, not applicable, because P2 had prednisone reactions and had to stop prednisone use in the subsequent treatment of anaphylactic reaction.
**6 months after stopping TCM. ND, not done.
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dairy restricted diet.
Pre TCM
This patient was diagnosed with milk allergy at 3 months
of age after an ER visit due to anaphylaxis (widespread
hives, vomiting and difficulty breathing) immediately
following ingestion of cow milk based formula. She
subsequently experienced numerous reactions; and the
frequency and severity of these reactions worsened over
time. Despite a dairy restricted diet, during the 2-year
period prior to starting TCM she experienced >100
reactions (at times a reaction every few days, averaging
50 reactions/year). Fifty events required prednisone and
epinephrine administration, 40 required ER visits, and 3
resulted in intensive care unit (ICU) admissions. In the
three months before TCM, her reactions became evenmore severe; 5 of 10 events required epinephrine and ER
visits. These reactions were characterized by hives,
rash, lip swelling, throat tightness, wheezing, stomach
pain, headache, weakness, dizziness, syncope, hypoxia,
and drop in blood pressure. Her overall severity score
during the 3-month period before beginning TCM
was 29 (Figures 1 and 3). Her reactions were triggered by
inhalation and contact in addition to accidental inges-
tion of trace amounts of dairy products. Anaphylaxis
events were so frequent and severe that she was un-
able to attend school in the 4 months prior to her
first TCM visit. She also complained of chronic stom-
ach discomfort. Her milk protein specific IgE levels
were elevated at 37.3 kU/L. She did not undergo milk
protein skin testing because her history of severe skin
contact induced reactions, raised concern that severe
reactions might occur.
Figure 1 Symptom scores before, during and after TCM treatment. Severity of symptoms, during the previous 3 month period and during
and post TCM therapy at different times as indicated were recorded in a patient history form and patient files. Blue bars indicate reaction scores
during the 3 months before TCM. Green bars indicate symptom scores during and after TCM as indicated. All patients experienced reductions in
symptom severity over the course of TCM. Lisann et al.
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Figure 2 Total symptom scores before and after TCM treatment.
Total symptom scores of reactions were calculated during the 3
month period before receiving TCM treatment and the last 3–6
months period of TCM therapy based on the data shown in Figure 1.
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This patient lives in another state that outside New York
state. The impact of these reactions on quality of life is
illustrated by the fact that the patient’s father drove for
three days to bring her to New York City for the first
TCM visit because of fear of a possible reaction to trace
amounts of milk protein while on an airliner. She was
prescribed all 4 TCM remedies: Remedy A, started with
1 pill, gradually increasing to 5 pills, 10 pills and 12 pills,
twice daily (b.i.d), and then three times daily (t.i.d.). 12Figure 3 P3 antigen specific-IgE levels before and after TCM. Prior to
which revealed poly-sensitization to multiple food and environmental aller
were above 17.6 kU/ L. His pre-TCM IgE levels >17.6 kU/L were all reducedcapsules t.i.d was the full dose for patients 12 and above
based on the manufacturing extraction yield of raw
herbs (Additional file 1: Herbal constituents and doses).
The protocol to gradually increase the dose was to en-
sure the safety and tolerability. Remedy B, 3 pills, b.i.d.;
Remedy C (bath additive) 2 packs per bath once a day
(q.d.), and Remedy D (cream) applied to her entire body,
including the face, q.d.. Since her reactions often began
with throat tightness or pain, Fructus Arctii Lappae,
which has been traditionally used for throat ailments
[29], was added during the treatment course. Acupunc-
ture was also performed at each visit. She tolerated the
medicine regimen very well and after approximately
3 months no longer complained of stomach discomfort
that she used to have before TCM. Follow-up visits took
place every 3–6 months, a total 8 visits. Her FSFA
slightly improved after 6 months of TCM and greatly
improved after 1.5 years of TCM, and she was able to
resume school. After 2 years of treatment, the number
of reactions was reduced by 90%. None required epi-
nephrine, or ER visit. Symptom severity was reduced by
56%, based on total scores (Figures 1 and 3). She was
able to work a summer job as a lifeguard, and she and
her father no longer feared flying to New York for her
two-year TCM visit. She experienced no reactions dur-
ing the final 6 months of TCM (Years 2–2.5) (Table 1,
Figures 1 and 3). Her baseline milk specific IgE level of
37.3kU/L has been declined to 19.0kU/L. Her FLIP score
reduced to 25 from 35. No abnormal liver and kidney
function test results before or after TCM therapy (AST,
20 and 18, reference 14-37u/L; ALT, 16 and 30, reference
8–36 U/L; BUN, 12 and 9, reference 7–25 mg/dL) were
observed. She has reached her primary goal of avoidingthe initial TCM clinic P3 underwent extensive IgE testing by his allergist
gens. Seventeen food and environmental allergen-specific IgE levels
by TCM therapy.
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TCM therapy with a new goal of maintaining the benefi-
cial effect and to possibly become tolerant to milk
allergens.
CASE 2
P2 is a 16 year-old female with physician diagnosed
severe tree nut allergy who began TCM therapy in June
20, 2012 with the goal of reducing her incidence of tree
nut-induced anaphylaxis.
Pre TCM
She was first diagnosed with severe nut allergy at age 13
after an ER visit due to anaphylaxis triggered by eating
nut containing foods in a Thai restaurant, exhibited as
widespread hives, lip swelling and vomiting, followed by
throat tightness and difficulty breathing. Despite removing
nuts from her diet, during the 2 years prior to starting
TCM she experienced 30 severe reactions (average 15
reactions/year) requiring 34 epinephrine and 30 additional
diphenhydramine doses (she had been on daily diphen-
hydramine and cetirizine during the 2 year period), and 10
emergency hospital admissions (Table 1). One episode
required 4 epinephrine doses prior to emergency hospital
admission following helicopter transport. She was most
sensitive to almonds, and vomited and developed wide
spread hives after skin prick testing with almond 2 years
prior to TCM. P2 has blood/needle phobias. She did not
undergo blood tests for specific IgEs against nuts. During
the year prior to initiating TCM, her reactions progressed
much more rapidly from hives and vomiting to hypoxia
and circulatory collapse. She was severely sensitive to trace
nut allergen exposure by inhalation and contact as well as
by ingestion. Her symptom score was 25 during the
3 months prior to initiating TCM (Figures 1 and 3). She
missed approximately 50% of school days and had to
withdraw from her school sports team. As a conse-
quence, she developed anxiety/depression and was on
sertraline during the 2 months prior to beginning TCM.
Her mother (an ER physician) arranged numerous con-
sultations with allergists. They were subsequently told
by an allergist that there was nothing more to be done,
and there was nothing on the horizon that would help
her severe nut anaphylaxis. After the mother read publi-
cations showing that TCM herbal medicines abolished
food anaphylaxis in murine models, they sought similar
therapy.
During and after TCM
This patient followed the same initial protocol as P1.
However, unlike P1, she responded relatively quickly;
experiencing only one reaction during the first 3 months
of treatment (moderate hives, face swelling, and throat
pain, but no gastrointestinal symptoms, wheezing,cardiovascular, or neurological symptoms), which was
treated with additional diphenhydramine. She was main-
tained on 10 pills Remedy A b.i.d. Her anxiety also dra-
matically improved and she discontinued sertraline after
2 months of TCM. After 4–6 months of TCM, she expe-
rienced two mild reactions. The first included mild
hives, rash, and lip swelling only, and was treated with
additional diphenhydramine. The second reaction con-
sisting of a few hives, did not require additional diphen-
hydramine. After 6 months, she discontinued daily anti-
histamine use (Table 1 P2). She experienced no reactions
during the final 3 months (months 10–12) of treatment.
Total symptom severity score declined from 25 to 0
(Figures 1 and 3). Since she lives in another country, her
mother had monthly phone consultations for the first
2 months, and then every 2–3 months plus email com-
munication until completing one year of TCM therapy,
at which time she passed a nut challenge. The tentative
12-month visit was cancelled. Her mother continued to
communicate by emails up to 6 months after challenge.
During this period she accidentally consumed nut-
containing pastry and experienced no allergic reaction.
She subsequently passed challenges with almond and
mixed nuts. Importantly, she remains free of allergy symp-
toms while consuming tree nuts ad libitum 6 months off
TCM. Her FLIP score was reduced from 39 to 0. This
patient achieved her primary goal. Laboratory data are not
available.
CASE 3
Patient 3 is a 9 year-old male with allergist diagnosed
severe tree nut and fruit allergies who began TCM therapy
in June 2013 with the goal of reducing the frequency of
his reactions.
Pre TCM therapy
This patient was diagnosed with nut allergy at 7 years of
age after an ER visit due to anaphylaxis (projectile vomit-
ing, inability to move his legs due to cramps, throat closed,
diffuse hives and breathing difficulty) after ingesting
chocolate containing mixed tree nuts. Despite an all nut
restricted diet, his reactions became more frequent and
severe. He also developed reactions to additional foods,
including coconut, sesame seed, certain fruits and wheat,
which he had previously tolerated. Reactions were trig-
gered by inhalation and contact as well as accidental
ingestion of trace amounts of offending foods. During the
prior 2 year period he experienced approximately 400
reactions (every few days and at times daily, averaging 200
reactions per year) while on daily levocetirizine. His aller-
gist added daily fexofenadine because levocetirizine alone
failed to reduce the number or severity of reactions during
the prior 6 months. However, his frequent reactions
did not decrease. His most common reactions included
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ile vomiting, and throat tightness. The most severe
reactions included wheezing, hypoxia, muscle cramping,
weakness, and increased heart rate. Five reactions required
epinephrine and ER visits. He had positive skin test results
to almond, pistachio, sesame, peanut, soy bean, coconut,
apple and wheat 6 months prior to TCM. Extensive serum
IgE testing ordered by his primary allergist 2 years and
one month prior to his initial TCM visit revealed that he
was poly sensitized to multiple food and environmental
allergens. His IgE levels to 65 food and environmental
allergens were elevated. Seventeen were above 17.6 KU/L
(classified as very high), 13 of these were to food allergens
(Figure 3). He had a history of reactions to all 13 foods,
but was most sensitive to almonds. He also complained of
chronic stomach discomfort and headaches, and had de-
veloped a sleep disorder approximately 6 months before
beginning TCM treatment.
During TCM
This patient underwent the same regimen as P1 and P2.
However, the maximum dose of Remedy A was 8 pills,
b.i.d (adjusted based on his age, approximately 1/3 of full
dose). He also received monthly acupuncture. The fre-
quency and severity of his reactions decreased by 50% dur-
ing the first 3 months of TCM (from 20 reactions per
month at baseline to 10 per month at 3 months of TCM).
During the 4–6 months treatment period, he experienced
only two mild reactions. He has discontinued fexofenadine.
After 7 months of TCM, he also discontinued levocetiri-
zine, and has experienced only one mild reaction treated
with diphenhydramine. His overall symptom score de-
clined from 24 to 1 (94% reduction, Figure 2). All 17
foods and environmental allergen-specific IgE levels,
previously above 17.6 kU/L, were reduced (Figure 3).
His liver and kidney function test results were all within
the normal range before and after TCM (AST, 26 and
23 U/L, reference 12-32U/L; ALT 15 and 18 U/L, refer-
ence 8–30 U/L; BUN, 11 and 8, reference 7–20 mg/dL).
His FLIP score was reduced from 37 to 22. In addition,
after the first 3 months of treatment, he no longer expe-
rienced stomach discomfort or headaches; and he no
longer has a sleep disorder. He reached his primary goal,
and is continuing TCM therapy to maintain the efficacy
and perhaps to induce a tolerance to some of the foods.
Discussion
This case study describes 3 FSFA patients who under-
went TCM therapy with the goal of reducing the fre-
quency and severity of their food induced anaphylactic
reactions. In all cases, food allergy was diagnosed after
ER visits due to anaphylactic reactions. Their FSFA
generated significant stress for their families. P1 ana-
phylaxis episodes began in infancy, and increased infrequency and severity over time. P2 had a 3 year, and
P3 had a 2 year period of anaphylaxis episodes that also
increased in frequency and severity over time prior to
TCM therapy. We therefore analyzed their reaction
history during the 2-year period prior to starting TCM.
We also conducted a separate analysis of frequency and
severity of their reactions during the 3-month period
immediately prior to starting TCM. All reported extraor-
dinarily frequent and severe reactions during the 2-year
pre-TCM period. Attempts to avoid ingestion of offend-
ing foods were not sufficient, because anaphylaxis in
these patients could also be triggered by inhalation and
skin exposure. The number of accidental reactions in
these patients appeared to be 15–100 times higher than
the recently reported rate of 0.8 reactions annually [6].
This might be due to their extreme sensitivity to minute
quantities of non-ingested allergen. All families denied
that any episode was associated with acute stress, ruling
out isolated panic disorder as responsible for the physio-
logic phenomena. Although the majority of clearly de-
fined food induced reactions are triggered by ingestion,
anaphylaxis due to non-ingested food allergen exposure
has also been reported. For example, Vitaliti et al. [8] de-
scribed a child who developed anaphylaxis after inhaling
lentil vapors. Tan et al. [10] reported severe food allergy
reactions following skin contact and inhalation of milk,
egg or peanut in 5 children. Liccardi et al. [11] reported a
severe systemic allergic reaction in a 16-year-old boy in-
duced by accidental skin contact with cow milk. A recent
large cohort study reported that although 80.7% of food
allergy reactions were triggered by ingestion, 12.9% were
triggered by skin contact, and 1.2% by inhalation [6].
Although the extremely severe FSFA in the patients
described in the present report represents only a fraction
of food allergy patients; this group of patients is most in
need of therapy. All families expressed frustration about
the lack of understanding by others, especially health care
providers, regarding how sensitive their children were to
food allergens.
This study is the first to demonstrate that comprehen-
sive TCM therapy can prevent or markedly reduce FSFA
and reduce antigen IgE levels. Mast cell and basophil
IgE sensitization and subsequent activation following
relevant antigen exposure are the key triggers of clinical
anaphylactic reactions. Because FSFA clinical expression
involves multiple organ systems, a combination of 4
TCM remedies was used for all 3 patients. The medi-
cinal properties of herbs in each formulation have been
studied in other contexts. Remedy A contains the 8
herbs in Wu Mei Wan (from which FAHF-1 and FAHF-
2 were developed), which originated from the classical
herbal formula described in the book “Shang Han Lun”
by Chinese physician Zhang Zhong-Jing (150 AD) used
to treat gastrointestinal conditions and anaphylactic-like
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model of food allergy, and suppresses IgE synthesis and
mast cell and basophil activation in animal models [17]
and human basophil activation ex vivo. Remedy A dif-
fers from FAHF-2 by not containing Coptis chinesis
(C. chinesis) but instead a 50% higher dose of P. chinesis
extract than that of C. chinesis in FAHF-2 [31]. Both herbs
are used similarly in TCM practice. In recent years, C.
chinesis has become increasingly expensive (7.5 times
more expensive than P. chinesis). Importantly P. chinesis
extract has been shown to inhibit IgE production in vitro
[26]. Remedy B, used to alleviate patients’ gastrointestinal
symptoms, containing 6 herbs is based on modified Xiang
Sha Yang Wei Wan, the classical herbal formula described
in the TCM book “Wan Bin Hui Chun” by Chinese phys-
ician Lon Tin Xian (1587 AD), which is used to reduce
stomach ache and indigestion [30]. In addition, since all
patients were highly sensitive to food allergen skin con-
tact, and since P. chinesis compounds inhibit mast cell
degranulation [17] and IgE production, a P. chinesis
containing bath additive (Remedy C), and a cream
(Remedy D) used to treat eczema [32] were also utilized.
Although all 3 patients had a remarkable response to
TCM therapy, P1 required longer treatment than P2 and
P3 before clinical improvement was evident. P1 experi-
enced no reactions only during the final 6 months of a
2.5 year treatment period. P2 and P3 showed more rapid
improvement, which became evident in the first 3 months
of TCM therapy. Of most significance is that P2 reestab-
lished full tolerance to almonds and other tree nuts, and
continues to tolerate all nuts 6 months off TCM. In parallel
with FSFA improvement, all patients’ chronic stomach dis-
comfort resolved after approximately 3 months of TCM,
and has not reoccurred. Their social activity and quality of
life are improved: P1 resumed school and took a summer
job, P2 resumed school sports and discontinued sertraline,
and P3 no longer has a sleep disorder. Their FLIP scores
are also reduced, most dramatically in P2 (from 39 to 0). In
addition to the reported subjective clinical information,
laboratory data were obtained from P1 and P3. These data
showed that TCM therapy reduced both patients’ IgE
levels, which is consistent with findings in animal food
allergy models [19], a cultured human B cell line [26], and
human PBMCs from food allergic children [33].
Adherence to this type of combined TCM therapy is
challenging because patients are required to adhere to a
protocol that includes consuming many pills daily, as
well as external treatment regimens. In contrast to a
recent report showing that subjects exhibited poor ad-
herence to a treatment protocol requiring consumption
of a large number of pills in a phase II trial [34], the
patients in this study strictly followed the TCM protocol
(documented by parents). Their motivation may be due
to their extreme sensitivity and history of frequentreactions. We do not know if all remedies used by these
patients were essential, and further study would be
required to determine their individual effects.
Diagnosis of IgE-mediated food allergy requires evi-
dence of both sensitization and clinical symptoms after
exposure to the allergen. Either skin-prick testing or
measurement of specific IgE levels is recommended for
identifying foods that may provoke IgE-mediated allergic
reactions [35]. P1 has evidence of milk IgE sensitization
and numerous well defined reactions to milk products
by inhalation and skin contact, in addition to accidental
ingestion. Although IgE testing was not performed, P2
exhibited systemic reactions (hives and vomiting) follow-
ing skin testing with mixed tree nuts. This together with
her history of well defined episodes of anaphylaxis made
P2 qualified for this case review based on our FSFA cri-
teria. Patient 3 had many positive skin test results and
positive IgE levels. He also had a history of reactions to
at least 13 foods before beginning TCM as illustrated in
Figure 3.
Although it is widely known that mast cells are activated
in the context of an allergic reaction by allergen-induced
cross-linking of surface IgE/FcεRI (the high-affinity recep-
tor for the Fc region of IgE), it should be recognized that
many other stimuli and conditions can cause mast cell
activation and result in anaphylaxis [36]. Frequent ana-
phylaxis in a patient should prompt a clinician to include
mast cell disorders in the differential diagnosis. Mast cell
activation disorder (MCAD) has been distinguished into
2 major forms, clonal and nonclonal. Systemic mastocy-
tosis (SM) and monoclonal mast cell activation disorder
(MMAS), common forms of primary MCAD, implicate
dysregulation of C-kit gene in a clonal population of
mast cells, leading to increased physical burden of mast
cells [36]. Skin lesions (eg, urticaria pigmentosa), recur-
rent unexplained anaphylaxis, and unexplained cytope-
nias are clinical characteristics [36]. Non-clonal mast
cell activation syndrome (nc-MCAS, MACS) is a com-
mon form of idiopathic MCAD [36,37]. Factors extrinsic
to mast cells lead to recurrent, inappropriate release of
mast cell mediators, including histamine and lipid medi-
ators. The differential expression and release mediators
of this multifaceted innate immune cell population leads
to different hypersensitivity symptoms –chronic urti-
caria, pruritis, flushing, gastrointestinal distress (nausea,
vomiting, abdominal pain, cramping, bloating), respira-
tory symptoms, cardiovascular compromise, and cogni-
tive impairment such as poor concentration and
memory and brain fog. Both primary and idiopathic
MCAD usually have no objective evidence of food spe-
cific IgE allergy by ImmunoCAP® and percutaneous test-
ing, which distinguishes them from IgE-mediated
hypersensitivity reactions, a form of secondary MCAD
[36,37]. All 3 cases reported in this study had elevation
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as well defined specific food exposure-induced reactions,
which is in agreement with food induced anaphylaxis [35].
In addition, none of these individuals exhibited urticaria
pigmentosa, chronic urticaria, pruritis, flushing, stomach
bloating, or brain fog. Thus MMAS or MACS was not
entertained in these cases.
Patient 1 had severe symptoms as a result of cow's
milk formula at 3 months of age. Food protein–induced
enterocolitis syndrome (FPIES) is in the differential diag-
nosis for this age group. FPIES has a unique clinical
expression that distinguishes it from IgE mediated food
anaphylaxis. Acute FPIES manifests as profuse repetitive
vomiting and lethargy, typically occurring 1–3 hours
after ingestion of the offending allergen, and occasionally
followed by diarrhea several hours later [38,39]. 90% of
children outgrew FPIES by 3 years of age. Diagnosis is
primarily based on history because specific IgE and skin
prick tests are typically negative [39-41]. Furthermore,
FPIES reactions do not involve skin [42]. P1 developed
widespread hives, projectile vomiting, and difficulty
breathing within minutes following ingestion of milk-
based formula. It is highly unlikely that these symptoms
would lead to a diagnosis of FPIES at time of presenta-
tion. This patient subsequently tested positive for milk
specific IgE. Her milk allergy persisted to adolescence
and became worse 2 years prior to TCM therapy despite
attempted dairy product avoidance, and her reactions
were often trigged by skin contact and inhalation of
trace amounts of milk allergen. Her reactions were acute,
starting with hives and progressing rapidly to respiratory
reactions; in most severe events, cardiovascular changes
were also seen. Overall, given the acute reactions, eleva-
tion of IgE, clinical expression and persistence of milk
allergy, and skin and inhalation induced reactions to trace
levels of milk protein, FPIES has not been considered.
Limitations of this study include the limited number
of cases, possible recall bias and lack of knowledge of
mechanisms underlying clinical effects. Patients did not
undergo diagnostic food challenge because of fear of
severe reactions, their convincing history of reactions,
rescue medication use and ER visits. Food challenge is
not necessary and may pose a potential risk in patients
with FSFA. This is in agreement with previous publica-
tions [10,27].
Conclusions
We observed 3 pediatric patients with extraordinarily fre-
quent and potentially life threatening severe food-induced
anaphylaxis, and found that combined TCM therapy suc-
cessfully prevented FSFA, thereby improving the quality of
life of patients and their families. Patients who experience
frequent and potentially fatal food-induced anaphylaxis
have severely limited capacity to participate in activities of“normal” daily life. Many of these patients have exhausted
all of their options and see no chance of improvement
through conventional treatments. The therapy presented
in the current case reports presents a potential option for
improvement in these patients. Prospective clinical studies
and randomized clinical trials that will further determine
the effectiveness in a large group of patients and assess
immunological changes are warranted.
Consent
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